Body Composition Analysis-Asia Pacific Market Status and Trend Report 2013-2023
Report Summary
Body Composition Analysis-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Body Composition Analysis industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Asia Pacific and Regional Market Size of Body Composition Analysis 2013-2017, and development forecast 2018-2023
Main market players of Body Composition Analysis in Asia Pacific, with company and product introduction, position in the Body Composition Analysis market
Market status and development trend of Body Composition Analysis by types and applications
Cost and profit status of Body Composition Analysis, and marketing status
Market growth drivers and challenges
The report segments the Asia Pacific Body Composition Analysis market as:
Asia Pacific Body Composition Analysis Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
China
Japan
Korea
India
Southeast Asia
Australia
Asia Pacific Body Composition Analysis Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Type I
Type II
Type III
Asia Pacific Body Composition Analysis Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Application 1
Application 2
Application 3
Asia Pacific Body Composition Analysis Market: Players Segment Analysis (Company and Product introduction, Body Composition Analysis Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare (UK)
Geratherm Medical AG (Germany)
Hologic, Inc. (US)
InBody Co., Ltd. (South Korea)
Iworx Systems, Inc. (US)
Jawon Medical Co. Ltd. (South Korea)
KORR Medical Technologies, Inc. (US)
Laica SpA (Italy)
MGC Diagnostics Corporation (US)
Microlife Medical Home Solutions, Inc. (US)
Mindray Medical International Limited (China)
Mortara Instrument, Inc. (US)
Nihon Kohden Corporation (Japan)
Noraxon U.S.A., Inc. (US)
Omron Healthcare, Inc. (US)
Parvo Medics (US)
Philips Healthcare (Netherlands)
RJL Systems, Inc. (US)
Schiller AG (Switzerland)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
Body Composition Analysis-Asia Pacific Market Status and Trend Report 2013-2023 offers a comprehensive analysis on Body Composition Analysis industry, standing on the readers? perspective, delivering detailed market data and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Whole Asia Pacific and Regional Market Size of Body Composition Analysis 2013-2017, and development forecast 2018-2023
Main market players of Body Composition Analysis in Asia Pacific, with company and product introduction, position in the Body Composition Analysis market
Market status and development trend of Body Composition Analysis by types and applications
Cost and profit status of Body Composition Analysis, and marketing status
Market growth drivers and challenges
The report segments the Asia Pacific Body Composition Analysis market as:
Asia Pacific Body Composition Analysis Market: Regional Segment Analysis (Regional Consumption Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
China
Japan
Korea
India
Southeast Asia
Australia
Asia Pacific Body Composition Analysis Market: Product Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Type I
Type II
Type III
Asia Pacific Body Composition Analysis Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Application 1
Application 2
Application 3
Asia Pacific Body Composition Analysis Market: Players Segment Analysis (Company and Product introduction, Body Composition Analysis Sales Volume, Revenue, Price and Gross Margin):
GE Healthcare (UK)
Geratherm Medical AG (Germany)
Hologic, Inc. (US)
InBody Co., Ltd. (South Korea)
Iworx Systems, Inc. (US)
Jawon Medical Co. Ltd. (South Korea)
KORR Medical Technologies, Inc. (US)
Laica SpA (Italy)
MGC Diagnostics Corporation (US)
Microlife Medical Home Solutions, Inc. (US)
Mindray Medical International Limited (China)
Mortara Instrument, Inc. (US)
Nihon Kohden Corporation (Japan)
Noraxon U.S.A., Inc. (US)
Omron Healthcare, Inc. (US)
Parvo Medics (US)
Philips Healthcare (Netherlands)
RJL Systems, Inc. (US)
Schiller AG (Switzerland)
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF BODY COMPOSITION ANALYSIS
1.1 Definition of Body Composition Analysis in This Report
1.2 Commercial Types of Body Composition Analysis
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Downstream Application of Body Composition Analysis
1.3.1 Application
1.3.2 Application
1.3.3 Application
1.4 Development History of Body Composition Analysis
1.5 Market Status and Trend of Body Composition Analysis 2013-2023
1.5.1 Asia Pacific Body Composition Analysis Market Status and Trend 2013-2023
1.5.2 Regional Body Composition Analysis Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Body Composition Analysis in Asia Pacific 2013-2017
2.2 Consumption Market of Body Composition Analysis in Asia Pacific by Regions
2.2.1 Consumption Volume of Body Composition Analysis in Asia Pacific by Regions
2.2.2 Revenue of Body Composition Analysis in Asia Pacific by Regions
2.3 Market Analysis of Body Composition Analysis in Asia Pacific by Regions
2.3.1 Market Analysis of Body Composition Analysis in China 2013-2017
2.3.2 Market Analysis of Body Composition Analysis in Japan 2013-2017
2.3.3 Market Analysis of Body Composition Analysis in Korea 2013-2017
2.3.4 Market Analysis of Body Composition Analysis in India 2013-2017
2.3.5 Market Analysis of Body Composition Analysis in Southeast Asia 2013-2017
2.3.6 Market Analysis of Body Composition Analysis in Australia 2013-2017
2.4 Market Development Forecast of Body Composition Analysis in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Body Composition Analysis in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Body Composition Analysis by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Body Composition Analysis in Asia Pacific by Types
3.1.2 Revenue of Body Composition Analysis in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Body Composition Analysis in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Body Composition Analysis in Asia Pacific by Downstream Industry
4.2 Demand Volume of Body Composition Analysis by Downstream Industry in Major Countries
4.2.1 Demand Volume of Body Composition Analysis by Downstream Industry in China
4.2.2 Demand Volume of Body Composition Analysis by Downstream Industry in Japan
4.2.3 Demand Volume of Body Composition Analysis by Downstream Industry in Korea
4.2.4 Demand Volume of Body Composition Analysis by Downstream Industry in India
4.2.5 Demand Volume of Body Composition Analysis by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Body Composition Analysis by Downstream Industry in Australia
4.3 Market Forecast of Body Composition Analysis in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BODY COMPOSITION ANALYSIS
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Body Composition Analysis Downstream Industry Situation and Trend Overview
CHAPTER 6 BODY COMPOSITION ANALYSIS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Body Composition Analysis in Asia Pacific by Major Players
6.2 Revenue of Body Composition Analysis in Asia Pacific by Major Players
6.3 Basic Information of Body Composition Analysis by Major Players
6.3.1 Headquarters Location and Established Time of Body Composition Analysis Major Players
6.3.2 Employees and Revenue Level of Body Composition Analysis Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BODY COMPOSITION ANALYSIS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare (UK)
7.1.1 Company profile
7.1.2 Representative Body Composition Analysis Product
7.1.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of GE Healthcare (UK)
7.2 Geratherm Medical AG (Germany)
7.2.1 Company profile
7.2.2 Representative Body Composition Analysis Product
7.2.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Geratherm Medical AG (Germany)
7.3 Hologic, Inc. (US)
7.3.1 Company profile
7.3.2 Representative Body Composition Analysis Product
7.3.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Hologic, Inc. (US)
7.4 InBody Co., Ltd. (South Korea)
7.4.1 Company profile
7.4.2 Representative Body Composition Analysis Product
7.4.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of InBody Co., Ltd. (South Korea)
7.5 Iworx Systems, Inc. (US)
7.5.1 Company profile
7.5.2 Representative Body Composition Analysis Product
7.5.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Iworx Systems, Inc. (US)
7.6 Jawon Medical Co. Ltd. (South Korea)
7.6.1 Company profile
7.6.2 Representative Body Composition Analysis Product
7.6.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Jawon Medical Co. Ltd. (South Korea)
7.7 KORR Medical Technologies, Inc. (US)
7.7.1 Company profile
7.7.2 Representative Body Composition Analysis Product
7.7.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of KORR Medical Technologies, Inc. (US)
7.8 Laica SpA (Italy)
7.8.1 Company profile
7.8.2 Representative Body Composition Analysis Product
7.8.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Laica SpA (Italy)
7.9 MGC Diagnostics Corporation (US)
7.9.1 Company profile
7.9.2 Representative Body Composition Analysis Product
7.9.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of MGC Diagnostics Corporation (US)
7.10 Microlife Medical Home Solutions, Inc. (US)
7.10.1 Company profile
7.10.2 Representative Body Composition Analysis Product
7.10.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Microlife Medical Home Solutions, Inc. (US)
7.11 Mindray Medical International Limited (China)
7.11.1 Company profile
7.11.2 Representative Body Composition Analysis Product
7.11.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Mindray Medical International Limited (China)
7.12 Mortara Instrument, Inc. (US)
7.12.1 Company profile
7.12.2 Representative Body Composition Analysis Product
7.12.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Mortara Instrument, Inc. (US)
7.13 Nihon Kohden Corporation (Japan)
7.13.1 Company profile
7.13.2 Representative Body Composition Analysis Product
7.13.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Nihon Kohden Corporation (Japan)
7.14 Noraxon U.S.A., Inc. (US)
7.14.1 Company profile
7.14.2 Representative Body Composition Analysis Product
7.14.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Noraxon U.S.A., Inc. (US)
7.15 Omron Healthcare, Inc. (US)
7.15.1 Company profile
7.15.2 Representative Body Composition Analysis Product
7.15.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Omron Healthcare, Inc. (US)
7.16 Parvo Medics (US)
7.17 Philips Healthcare (Netherlands)
7.18 RJL Systems, Inc. (US)
7.19 Schiller AG (Switzerland)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BODY COMPOSITION ANALYSIS
8.1 Industry Chain of Body Composition Analysis
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BODY COMPOSITION ANALYSIS
9.1 Cost Structure Analysis of Body Composition Analysis
9.2 Raw Materials Cost Analysis of Body Composition Analysis
9.3 Labor Cost Analysis of Body Composition Analysis
9.4 Manufacturing Expenses Analysis of Body Composition Analysis
CHAPTER 10 MARKETING STATUS ANALYSIS OF BODY COMPOSITION ANALYSIS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
1.1 Definition of Body Composition Analysis in This Report
1.2 Commercial Types of Body Composition Analysis
1.2.1 Type I
1.2.2 Type II
1.2.3 Type III
1.3 Downstream Application of Body Composition Analysis
1.3.1 Application
1.3.2 Application
1.3.3 Application
1.4 Development History of Body Composition Analysis
1.5 Market Status and Trend of Body Composition Analysis 2013-2023
1.5.1 Asia Pacific Body Composition Analysis Market Status and Trend 2013-2023
1.5.2 Regional Body Composition Analysis Market Status and Trend 2013-2023
CHAPTER 2 ASIA PACIFIC MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Status of Body Composition Analysis in Asia Pacific 2013-2017
2.2 Consumption Market of Body Composition Analysis in Asia Pacific by Regions
2.2.1 Consumption Volume of Body Composition Analysis in Asia Pacific by Regions
2.2.2 Revenue of Body Composition Analysis in Asia Pacific by Regions
2.3 Market Analysis of Body Composition Analysis in Asia Pacific by Regions
2.3.1 Market Analysis of Body Composition Analysis in China 2013-2017
2.3.2 Market Analysis of Body Composition Analysis in Japan 2013-2017
2.3.3 Market Analysis of Body Composition Analysis in Korea 2013-2017
2.3.4 Market Analysis of Body Composition Analysis in India 2013-2017
2.3.5 Market Analysis of Body Composition Analysis in Southeast Asia 2013-2017
2.3.6 Market Analysis of Body Composition Analysis in Australia 2013-2017
2.4 Market Development Forecast of Body Composition Analysis in Asia Pacific 2018-2023
2.4.1 Market Development Forecast of Body Composition Analysis in Asia Pacific 2018-2023
2.4.2 Market Development Forecast of Body Composition Analysis by Regions 2018-2023
CHAPTER 3 ASIA PACIFIC MARKET STATUS AND FORECAST BY TYPES
3.1 Whole Asia Pacific Market Status by Types
3.1.1 Consumption Volume of Body Composition Analysis in Asia Pacific by Types
3.1.2 Revenue of Body Composition Analysis in Asia Pacific by Types
3.2 Asia Pacific Market Status by Types in Major Countries
3.2.1 Market Status by Types in China
3.2.2 Market Status by Types in Japan
3.2.3 Market Status by Types in Korea
3.2.4 Market Status by Types in India
3.2.5 Market Status by Types in Southeast Asia
3.2.6 Market Status by Types in Australia
3.3 Market Forecast of Body Composition Analysis in Asia Pacific by Types
CHAPTER 4 ASIA PACIFIC MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Demand Volume of Body Composition Analysis in Asia Pacific by Downstream Industry
4.2 Demand Volume of Body Composition Analysis by Downstream Industry in Major Countries
4.2.1 Demand Volume of Body Composition Analysis by Downstream Industry in China
4.2.2 Demand Volume of Body Composition Analysis by Downstream Industry in Japan
4.2.3 Demand Volume of Body Composition Analysis by Downstream Industry in Korea
4.2.4 Demand Volume of Body Composition Analysis by Downstream Industry in India
4.2.5 Demand Volume of Body Composition Analysis by Downstream Industry in Southeast Asia
4.2.6 Demand Volume of Body Composition Analysis by Downstream Industry in Australia
4.3 Market Forecast of Body Composition Analysis in Asia Pacific by Downstream Industry
CHAPTER 5 MARKET DRIVING FACTOR ANALYSIS OF BODY COMPOSITION ANALYSIS
5.1 Asia Pacific Economy Situation and Trend Overview
5.2 Body Composition Analysis Downstream Industry Situation and Trend Overview
CHAPTER 6 BODY COMPOSITION ANALYSIS MARKET COMPETITION STATUS BY MAJOR PLAYERS IN ASIA PACIFIC
6.1 Sales Volume of Body Composition Analysis in Asia Pacific by Major Players
6.2 Revenue of Body Composition Analysis in Asia Pacific by Major Players
6.3 Basic Information of Body Composition Analysis by Major Players
6.3.1 Headquarters Location and Established Time of Body Composition Analysis Major Players
6.3.2 Employees and Revenue Level of Body Composition Analysis Major Players
6.4 Market Competition News and Trend
6.4.1 Merger, Consolidation or Acquisition News
6.4.2 Investment or Disinvestment News
6.4.3 New Product Development and Launch
CHAPTER 7 BODY COMPOSITION ANALYSIS MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
7.1 GE Healthcare (UK)
7.1.1 Company profile
7.1.2 Representative Body Composition Analysis Product
7.1.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of GE Healthcare (UK)
7.2 Geratherm Medical AG (Germany)
7.2.1 Company profile
7.2.2 Representative Body Composition Analysis Product
7.2.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Geratherm Medical AG (Germany)
7.3 Hologic, Inc. (US)
7.3.1 Company profile
7.3.2 Representative Body Composition Analysis Product
7.3.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Hologic, Inc. (US)
7.4 InBody Co., Ltd. (South Korea)
7.4.1 Company profile
7.4.2 Representative Body Composition Analysis Product
7.4.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of InBody Co., Ltd. (South Korea)
7.5 Iworx Systems, Inc. (US)
7.5.1 Company profile
7.5.2 Representative Body Composition Analysis Product
7.5.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Iworx Systems, Inc. (US)
7.6 Jawon Medical Co. Ltd. (South Korea)
7.6.1 Company profile
7.6.2 Representative Body Composition Analysis Product
7.6.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Jawon Medical Co. Ltd. (South Korea)
7.7 KORR Medical Technologies, Inc. (US)
7.7.1 Company profile
7.7.2 Representative Body Composition Analysis Product
7.7.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of KORR Medical Technologies, Inc. (US)
7.8 Laica SpA (Italy)
7.8.1 Company profile
7.8.2 Representative Body Composition Analysis Product
7.8.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Laica SpA (Italy)
7.9 MGC Diagnostics Corporation (US)
7.9.1 Company profile
7.9.2 Representative Body Composition Analysis Product
7.9.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of MGC Diagnostics Corporation (US)
7.10 Microlife Medical Home Solutions, Inc. (US)
7.10.1 Company profile
7.10.2 Representative Body Composition Analysis Product
7.10.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Microlife Medical Home Solutions, Inc. (US)
7.11 Mindray Medical International Limited (China)
7.11.1 Company profile
7.11.2 Representative Body Composition Analysis Product
7.11.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Mindray Medical International Limited (China)
7.12 Mortara Instrument, Inc. (US)
7.12.1 Company profile
7.12.2 Representative Body Composition Analysis Product
7.12.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Mortara Instrument, Inc. (US)
7.13 Nihon Kohden Corporation (Japan)
7.13.1 Company profile
7.13.2 Representative Body Composition Analysis Product
7.13.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Nihon Kohden Corporation (Japan)
7.14 Noraxon U.S.A., Inc. (US)
7.14.1 Company profile
7.14.2 Representative Body Composition Analysis Product
7.14.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Noraxon U.S.A., Inc. (US)
7.15 Omron Healthcare, Inc. (US)
7.15.1 Company profile
7.15.2 Representative Body Composition Analysis Product
7.15.3 Body Composition Analysis Sales, Revenue, Price and Gross Margin of Omron Healthcare, Inc. (US)
7.16 Parvo Medics (US)
7.17 Philips Healthcare (Netherlands)
7.18 RJL Systems, Inc. (US)
7.19 Schiller AG (Switzerland)
CHAPTER 8 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF BODY COMPOSITION ANALYSIS
8.1 Industry Chain of Body Composition Analysis
8.2 Upstream Market and Representative Companies Analysis
8.3 Downstream Market and Representative Companies Analysis
CHAPTER 9 COST AND GROSS MARGIN ANALYSIS OF BODY COMPOSITION ANALYSIS
9.1 Cost Structure Analysis of Body Composition Analysis
9.2 Raw Materials Cost Analysis of Body Composition Analysis
9.3 Labor Cost Analysis of Body Composition Analysis
9.4 Manufacturing Expenses Analysis of Body Composition Analysis
CHAPTER 10 MARKETING STATUS ANALYSIS OF BODY COMPOSITION ANALYSIS
10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.1.3 Marketing Channel Development Trend
10.2 Market Positioning
10.2.1 Pricing Strategy
10.2.2 Brand Strategy
10.2.3 Target Client
10.3 Distributors/Traders List
CHAPTER 11 REPORT CONCLUSION
CHAPTER 12 RESEARCH METHODOLOGY AND REFERENCE
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Reference
